Cargando…
Dangerous Liaisons: Tau Interaction with Muscarinic Receptors
The molecular processes underlying neurodegenerative diseases (such as Alzheimer's Disease - AD) remain poorly understood. There is also an imperative need for disease-modifying therapies in AD since the present treatments, acetylcholinesterase inhibitors and NMDA antagonists, do not halt its p...
Autores principales: | Wysocka, Adrianna, Palasz, Ewelina, Steczkowska, Marta, Niewiadomska, Grazyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509759/ https://www.ncbi.nlm.nih.gov/pubmed/32329686 http://dx.doi.org/10.2174/1567205017666200424134311 |
Ejemplares similares
-
Cholinergic and inflammatory phenotypes in transgenic tau mouse models of Alzheimer’s disease and frontotemporal lobar degeneration
por: Cranston, Anna L, et al.
Publicado: (2020) -
Tau Oligomers Neurotoxicity
por: Niewiadomska, Grazyna, et al.
Publicado: (2021) -
BDNF as a Promising Therapeutic Agent in Parkinson’s Disease
por: Palasz, Ewelina, et al.
Publicado: (2020) -
Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease
por: Palasz, Ewelina, et al.
Publicado: (2019) -
Dangerous Liaisons: Interactions of Cryptococcus neoformans with Host Phagocytes
por: Gaylord, Elizabeth A., et al.
Publicado: (2020)